In-patient management and treatment satisfaction after intravitreous plasminogen activator injection

  • Maneli Mozaffarieh
  • Harald Heinzl
  • Stefan Sacu
  • Andreas WedrichEmail author
Clinical Investigation



To assess patient satisfaction after intravitreous plasminogen activator injections for subretinal hemorrhages secondary to age-related macular degeneration (AMD) and to analyse how it relates to the patients' postoperative visual and functional abilities. Further, to suggest ways to improve in-patient management and thereby treatment satisfaction.


A consecutive series of 101 patients with a subretinal hemorrhage of at least one disk diameter were enrolled in this longitudinal prospective study conducted during 2001–2004. After complete preoperative eye examination all patients were treated with intravitreal injection of 25 μg recombinant tissue plasminogen activator (rTPA) and 0.5 ml sulphur hexafluoride gas (SF6), followed by face-down positioning for 1 week. Patient satisfaction was assessed using standardised questionnaires administered postoperatively at 4 and 12 months. Outcome measures were: (1) responses to the patient satisfaction survey, (2) degree of satisfaction with in-patient management, (3) subjective change in the patients' functional status, and (4) visual acuity results.


Whereas the patients' actual functional status deteriorated from a median value of 2.4 at 4 months to 3.4 at 12 months, their recall of their preoperative functional status shifted from a median value of 4.2 to to 2.3, consecutively. Twelve months after treatment, 75% of patients reported an improved visual acuity, however, only 12% reported satisfaction with treatment. 67.4–87% of patients were dissatisfied with various areas of in-patient management.


Satisfaction with plasminogen activator injection treatment is low even though patients experience an improved visual and functional status at 12 months. This suggests that the current system requires improvement in certain areas such as in-patient management.


Intravetreous injection Plasminogen activator injection Subretinal hemmorhage Age-related macular degeneration Patients’ satisfaction 



We would like to thank all patients who actively took part in this study and made it possible. We would also like to thank Professor Frischenschlager, for his wise suggestions on cognition.


  1. 1.
    Avery RL, Fekrat S, Hawkins BS et al. (1996) Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina 16:183–189PubMedCrossRefGoogle Scholar
  2. 2.
    Barnes PM, Powell-Griner E, McFann K et al. (2004) Complementary and alternative medicine use among adults: United States, 2002. Adv Data 27:1–19Google Scholar
  3. 3.
    Bennett AR, Folk JC, Blodi C et al. (1990) Factors prognostic of visual outcome in patients with subretinal hemorrhage. Am J Ophthalmol 109:33–37PubMedGoogle Scholar
  4. 4.
    Cho YC, Tsay SL (2004) The effect of acupressure with massage on fatigue and depression in patients with end-stage renal disease. J Nurs Res 12:51–59PubMedGoogle Scholar
  5. 5.
    Clearly PD, Mc Neil BJ (1988) Patient satisfaction as an indicator of quality of care. Inquiry 25:25–36PubMedGoogle Scholar
  6. 6.
    Dawn AG, Santiago-Turla C, Lee PP (2003) Patient expectations regarding eye care. Arch Ophthalmol 121:762–768CrossRefPubMedGoogle Scholar
  7. 7.
    Dolinsky AL (1995) Complaint intensity and health care services: a framework to establish priorities for quality improvements can be used to improve patient satisfaction. J Health Care Marketing 15:42–47Google Scholar
  8. 8.
    Edge J (2003) A pilot study addressing the effect of aromatherapy massage on mood, anxiety and relaxation in adult mental health. Complement Ther Nurs Midwifery 9:90–97CrossRefPubMedGoogle Scholar
  9. 9.
    Hall JA, Epstein AM, DeCiantis ML et al. (1993) Physicians’ liking for their patients: more evidence for the role of affect in medical care. Health Psychol 12:140–146CrossRefPubMedGoogle Scholar
  10. 10.
    Hall JA, Roter DL, Katz NR (1988) Meta-analysis of correlates of provider behaviour in medical encounters. Med Care 26:657–675PubMedCrossRefGoogle Scholar
  11. 11.
    Hall NF, Gale CR (2002) Prevention of age-related macular degeneration. BMJ 325:1–2CrossRefPubMedGoogle Scholar
  12. 12.
    Herriot W (1996) Intravitreal gas and TPA: an outpatient procedure for subretinal hemorrhage. Presented at the Vitrectomy Meeting; October 10-15, Vail, ColoradoGoogle Scholar
  13. 13.
    Hesse L, Kroll P (1997) Successful treatment of acute subretinal hemorrhage in age-related macular degeneration by combined intravitreal injection of recombinant tissue plasminogen activator and gas. Adv Ther 14:275–280PubMedGoogle Scholar
  14. 14.
    Holladay JT, Prager TC (1991) Mean visual acuity (letter). Am J Ophthalmol 111:372–374PubMedGoogle Scholar
  15. 15.
    Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6:65–70Google Scholar
  16. 16.
    Howe LJ (2003) Management of age-related macular degeneration: still room for improvement. Br J Ophthalmol 87:375CrossRefPubMedGoogle Scholar
  17. 17.
    Ibanez HE, Williams DF, Thomas MA et al. (1995) Surgical removal of submacular hemorrhage. A series of 47 consecutive cases. Arch Ophthalmol 113:62–69PubMedGoogle Scholar
  18. 18.
    Janis J, Mann L (1977) Decision making: a psychological analysis of conflict, choice and commitment. Free Press, New YorkGoogle Scholar
  19. 19.
    Kaplan SH, Greenfield S, Ware JE Jr (1985) Expanding patient involvement in care. Effects on patient outcomes. Ann Intern Med 102:520–528PubMedGoogle Scholar
  20. 20.
    Kaplan SH, Greenfield S, Ware JE Jr (1989) Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care S1:10–27Google Scholar
  21. 21.
    Kincey J, Bradshaw P, Ley P (1975) Patients' satisfaction and reported acceptance of advice in general practice. J R Coll Gen Pract 25:558–576PubMedGoogle Scholar
  22. 22.
    Krepler K, Kruger A, Tittl M et al. (2000) Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration. Retina 20:251–256CrossRefPubMedGoogle Scholar
  23. 23.
    Mainz J (2004) Quality indicators: essential for quality improvement. Int J Qual Health Care 16:i1–i2CrossRefGoogle Scholar
  24. 24.
    Mitchell J, Bradley P, Ffytche T et al. (2002) Perceived quality of health care in macular disease: a survey of members of the Macular Disease Society. Br J Ophthalmol 86:777–781CrossRefPubMedGoogle Scholar
  25. 25.
    Monestam E, Wachtmeister L (1999) Dissatisfaction with cataract surgery in relation to visual results in a population-based study in Sweden. J Cataract Refract Surg 25:1127–1134CrossRefPubMedGoogle Scholar
  26. 26.
    Mozaffarieh M, Benesch T, Krepler K et al. (2005) Photocoagulation for diabetic retinopathy: determinants of patient satisfaction and the patient-provider relationship. Acta Ophthalmol Scand 83:316–321CrossRefPubMedGoogle Scholar
  27. 27.
    Nelson CW, Niederberger J (1990) Patient satisfaction surveys: an opportunity for total quality improvement. Hosp Health Serv Admin 35:409–427Google Scholar
  28. 28.
    Roter DL (1977) Patient participation in patient-provider interactions: the effects of patient question asking on the quality of interaction,satisfaction and compliance. Health Educ Monogr 5:281–315PubMedGoogle Scholar
  29. 29.
    Scheider A, Gündisch O, Kampik A (1999) Surgical extraction of subfoveal choroidal new vessels and submacular haemorrhage in age-related macular degeneration: results of a prospective study. Graefe's Arch Clin Exp Ophthalmol 237:10–15CrossRefGoogle Scholar
  30. 30.
    Scott IU, Smiddy WE, Feuer W et al. (1998) Vitreoretinal surgery outcomes. Results of a patient satisfaction/functional status survey. Ophthalmology 105:795–803CrossRefPubMedGoogle Scholar
  31. 31.
    Scupola A, Coscas G, Soubrane G et al. (1999) Natural history of macular subretinal hemorrhage in age-related macular degeneration. Ophthalmologica 213:97–102CrossRefPubMedGoogle Scholar
  32. 32.
    Tsai SC, Lin JM, Chen HY (2003) Intravitreous recombinant tissue plasminogen activator and gas to treat submacular hemorrhage in age-related macular degeneration. Kaohsiung J Med Sci 19:608–616PubMedCrossRefGoogle Scholar
  33. 33.
    Wade EC, Flynn HW, Olsen KR et al. (1990). Subretinal hemmorhage management by pars plana vitrectomy and internal drainage. Arch Ophthalmol 108:973–978PubMedGoogle Scholar
  34. 34.
    Walach H, Guthlin C, Konig M (2003) Efficacy of massage therapy in chronic pain: a pragmatic randomized trial. J Altern Complement Med 9:837–846CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Maneli Mozaffarieh
    • 1
  • Harald Heinzl
    • 2
  • Stefan Sacu
    • 1
  • Andreas Wedrich
    • 3
    Email author
  1. 1.Department of OphthalmologyMedical University of ViennaViennaAustria
  2. 2.Core Unit for Medical Statistics and InformaticsMedical University of ViennaViennaAustria
  3. 3.Department of OphthalmologyMedical University of GrazGrazAustria

Personalised recommendations